# K910720: Bard Biopty-Cut Biopsy Needle with Spacer

- Pathway: 510(k) (Traditional)
- Applicant: C.R. Bard, Inc.
- Decided: Jun 10, 1991 after 110 days
- Product code: FCG (Biopsy Needle)
- Device class: 2
- Regulation: 21 CFR 876.1075
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
3 later devices descend from it; 1 cites it directly.
0 of 4 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA has not posted a summary or statement for it, so its predicates are not known.

## Most influential descendants
- K962077: Bard Biopty-Cut Biopsy Needle/with Spacer (1996), 2 descendants of its own
- K191315: Remington Medical, Inc. Automatic Cutting Needle (NAC) (2019), 0 descendants of its own
- K110112: Cell-Tissue Converter (CTC) Syringe with Needle (2011), 0 descendants of its own

Source page: https://510kreport.com/device/K910720
Methodology: https://510kreport.com/methodology